Introduction
Streptococcus (S.) bovis (Sb) is a group of gram-positive cocci that can be found as part of the human gastrointestinal microbiota in 5% to 16% of normal individuals. 1-3 However, it causes bacteremia and endocarditis, particularly in older people and in southern Europe. 1, 2 Sb is the second most common cause of endocarditis from streptococci and is responsible for up to 15% of bacterial endocarditis. 1, 3, 4 An association between colorectal neoplasm (CRN) and Sb bacteremia/endocarditis was first suggested in 1951. 5 Since then, this relation has been extensively established in the literature, with variable percentages. [6] [7] [8] [9] [10] However, the extent and nature of this association are still not completely understood. 6, 7 More recent studies have highlighted the frequent association between Sb infection and chronic liver/biliary tract disorders as predisposing conditions. 1, 3 Streptococcal taxonomy has progressively changed over time, based on molecular characteristics. Nevertheless, current nomenclature has not been embraced by the majority of clinicians. 1, 3, 11, 12 This lack of uniform microbiological classification in scientific literature has led to an underestimation of the relationship between Sb and CRN, because not all genospecies seem to be as closely related to colonic malignancies. 7, 11 Several studies have shown that S. gallolyticus subsp. gallolyticus (formerly called Sb biotype I) is strongly related to the presence of premalignant colonic lesions and colonic cancer, up to 80%, that markedly exceeds the normal incidence of CRN in the asymptomatic population. 1, 2, 6, 7, 13 Also, it has been shown that S. gallolyticus subsp. infantarius and S.gallolyticus subsp. lutetiensis (former Sb biotype II/1) as well as S. gallolyticus subsp. pasteurianu (former Sb biotype II/2) are less often associated with endocarditis and colorectal cancer, but frequently associated with other types of infection and non-CRN. 8, 13 As a matter of fact, 94% of Sb bacteremia associated with colorectal cancer is in fact due to S. gallolyticus subsp. gallolyticus while only 18% is associated with the other Sb subspecies. 7 The incidence of CRN varies widely among countries. In the developed world, including Portugal, CRN represents a major public health problem. Several patients with Sb bacteremia have no clinical signs or symptoms referable to gastrointestinal (GI) tract, so CRN is solely discovered on the basis of Sb infection in these patients. 9 Furthermore, it is known that colonic neoplasm may arise years after the presentation of Sb bacteremia. 4, 7 Therefore, the early detection of CRN is one of the great challenges in the battle against this disease. Nevertheless, only limited information is available as to whether any clinical characteristics of bacteremic patients are specifically associated with CRN. 8 S. gallolyticus subsp. gallolyticus related diagnostic tools may aid CRN screening programs and, thereby, contribute to a decrease in the morbidity and mortality associated with this disease. 11 The aim of this study was to review all Sb bacteremic episodes documented over the last 17 years at a single tertiary-care centre, focusing on demographic and clinical associations in relation to the different subspecies.
Material and Methods
We performed a retrospective analysis of patients with Sb bacteremia admitted to our Internal Medicine department from january 2000 to december 2016. All Sb isolates recovered from blood cultures within this period were studied. Clinical charts of patients were reviewed. Coimbra Hospital and University Center (CHUC) is a tertiary-care centre and university hospital in Portugal, with a reference population of 2 million inhabitants. 
Results
Fourty-six patients with S. bacteremia were identified (range 0-10 cases per year), with a median age of 71 years, among which 33 (71.7%) were males. Endocarditis was the main source of infection (n = 14; 30.4%), followed by hepatobiliary/GI infection (n = 13; 28.3%), primary bacteremia (n = 11; 23.9%), pneumonia (n = 4; 8.7%), bone/joint infection (n = 3; 6.5%) and central nervous system (CNS) infection (n = 1; 2.2%).
Of the 46 patients, 13 (28.3%) concomitantly had heart disease, 11 (23.9%) had diabetes, 10 (21.7%) had endstage renal disease (ESLD), 9 (19.6%) had liver cirrhosis and 9 (19.6%) had chronic obstructive pulmonary disease (COPD). A history of malignancy prior to the episode of Sb bacteremia had been established in 9 patients (19.6%), mainly outside the gastrointestinal system. Full colonoscopic examination was performed in 26 (56.5%) patients. Among these, 16 (61.5%) were found to have a CRN. S. gallolyticus subsp. gallolyticus accounted for 19 cases (41.3%), S. gallolyticus subsp. pasteurianus for 7 cases (15.2%) and S. gallolyticus subsp. infantarius for one (2.2%). In the remaining cases (n = 19; 41.3%), molecular identification was not performed. In our study there was only one case (2.2%) of meningitis within the S. gallolyticus subsp. gallolyticus group. Gender distribution did not differ between the two main subspecies (S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus), as well as the median age of patients, comordities and laboratory data ( Table 1 , grade of liberty 18). Endocarditis was the main source of infection in patients infected with S. gallolyticus subsp. gallolyticus (n = 8; 42.1%), as opposed to the S. gallolyticus subsp. pasteurianus group in which no endocarditis case was recorded (p < 0.05). Bacteremia cases due to S. gallolyticus subsp. pasteurianus were more likely to have an hepatobiliary/GI source (n = 4; 57.1%) than bacteremia cases due to S. gallolyticus subsp. gallolyticus -only 2 patients (10.5%) within this group had an hepatobiliary/GI infection (p < 0.05). Among patients who underwent colonoscopy (n = 26), the number of cases in whom a CRN was found was significantly higher in the S. gallolyticus subsp. gallolyticus group (n = 10/12; 83.3%) than in the S. gallolyticus subsp. pasteurianus group (n = 1/5; 20.0%), p < 0.05. Indeed, there were important differences between patients who developed CRN and those who did not, with regard to the Sb subspecies and the source of infection (Table 2 , grade of liberty 21). While most CRN patients had endocarditis (n = 10/16; 62.5%), no cases of this infection were found on the non-CRN group (p < 0.05). On the other hand, most patients who did not develop CRN had bacteremia from a hepatobiliary/GI source (n = 6/10; 60.0%) versus 
Discussion
We observed that endocarditis was the main source of infection (30.4%). According to other investigators, the occurrence of endocarditis in patients with Sb bacteremia varies from 25% to 100%. 1, 9, 10 In our study, endocarditis was diagnosed exclusively in S. gallolyticus subsp. gallolyticus cases, which might be explained by a greater capacity of biofilm formation by this subspecies and consequently a higher risk of endocarditis. 1, 13 It has been stated that the relationship between S. gallolyticus subsp. gallolyticus endocarditis and colonic tumors suggests the existence of certain adhesins on the cell wall of these bacteria allowing the colonization of both colonic and vascular tissues. 7, 11 The rate of patients undergoing colonic evaluation in our study (56,5%) did not differ much from that reported in previous literature. 1 In patients with Sb bacteremia, neither age, gender, pre-existing comorbidities or laboratory data were significantly associated with CRN. Only infection with S. gallolyticus subsp. gallolyticus and endocarditis were found to be associated factors. Conversely, S. gallolyticus subsp. pasteurianus infection cases were associated with hepatobiliary/GI disease. The majority of patients infected with S. gallolyticus subsp. gallolyticus developed CRN (83.3%). At the opposite, CRN prevalence in patients infected with S.gallolyticus subsp. pasteurianus (20.0%) is similar to that found in the general asymptomatic population, which ranges between 23% and 41%. 6 The clinical relationship between Sb bacteremia and underlying GI diseases has been well-known for years. 3, 4, 6 However, to date, there has been no satisfactory explanation regarding the pathophysiologic mechanism for this association. 3, 6, 13 Likewise, it remains controversial as to whether Sb plays an etiological role in the development of colorectal tumors or is a consequence of the disease. The relationship between Sb/S. gallolyticus subsp. gallolyticus infection and the progressive development of malignant disease in preneoplastic adenomatous polyps was supported by recent reports. 14, 15 Several hypothesis have been proposed, such as the carcinogenic properties of Sb cell wall antigens or chronic Sb infection and inflammation. 4, 7 Moreover, recent studies have suggested the role of hepatobiliary disorders as predisposing factors for CRN in association with Sb infection, by a mechanism of bacterial translocation in the setting of decreased reticuloendothelial phagocytic function and impaired secretion of intestinal luminal immunoglobulins. 6, 7 Unlike other bacteria, Sb/S. gallolyticus subsp. gallolyticus is able to grow in bile, bypassing the hepatic reticulo-endothelial system and easily accessing systemic circulation. 7 Current studies have been focusing on whether Sb bacteremia can be established as an independent predictor of malignancy. 4 Seroprevalence of Sb/S.gallolyticus subsp. gallolyticus is considered as a candidate practical marker for the early prediction of an underlying bowel lesion at high risk population. 7 Our study has several limitations, including its retrospective design, the lack of control over the quality of the medical records reviewed and the fact that it was conducted in a single center. Patients approach was heterogeneous, since many did not perform colonic evaluation following the episode of bacteremia. Also, it was not possible to determine the subspecies in almost half the strains of Sb as only conventional methods for bacterial identification were used in the first years of study. Moreover, we did not approach the possible association of Sb bacteremia with nutritional factors in order to examine the role of diet in human intestinal colonization by different Sb species.
Conclusion
Our results suggest the existence of two clinical and microbiological patterns among patients with Sb bacteremia. Subjects infected with S. gallolyticus subsp. gallolyticus tended to present with endocarditis and to have positive findings in the colonic evaluation. Conversely, patients with S. gallolyticus subsp. pasteurianus bacteremia were more likely to have hepatobiliary/GI disease, which is in agreement with previous studies. Further research is required to determine the pathogenic mechanisms in which different subspecies of Sb may be implicated in the development of CRN. Early diagnosis of colorectal adenomas or carcinomas via detection of Sb/S. gallolyticus subsp. gallolyticus serology seems promising in screening high risk groups for colorectal cancer. 7 ■ Conflitos de Interesse: Os autores declaram a inexistência de conflitos de interesse na realização do presente trabalho.
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